| Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation F Wang, J Travins, B DeLaBarre, V Penard-Lacronique, S Schalm, ... Science 340 (6132), 622-626, 2013 | 945 | 2013 |
| Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis D Anastasiou, Y Yu, WJ Israelsen, JK Jiang, MB Boxer, BS Hong, ... Nature chemical biology 8 (10), 839-847, 2012 | 785 | 2012 |
| AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations K Yen, J Travins, F Wang, MD David, E Artin, K Straley, A Padyana, ... Cancer discovery 7 (5), 478-493, 2017 | 429 | 2017 |
| Discovery of AG-120 (Ivosidenib): a first-in-class mutant IDH1 inhibitor for the treatment of IDH1 mutant cancers J Popovici-Muller, RM Lemieux, E Artin, JO Saunders, FG Salituro, ... ACS medicinal chemistry letters 9 (4), 300-305, 2018 | 393 | 2018 |
| Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo J Popovici-Muller, JO Saunders, FG Salituro, JM Travins, S Yan, F Zhao, ... ACS medicinal chemistry letters 3 (10), 850-855, 2012 | 244 | 2012 |
| Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2 MP Clark, MW Ledeboer, I Davies, RA Byrn, SM Jones, E Perola, A Tsai, ... Journal of medicinal chemistry 57 (15), 6668-6678, 2014 | 222 | 2014 |
| Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin. MN James, A Sielecki, F Salituro, DH Rich, T Hofmann Proceedings of the National Academy of Sciences 79 (20), 6137-6141, 1982 | 221 | 1982 |
| Small molecule activation of PKM2 in cancer cells induces serine auxotrophy C Kung, J Hixon, S Choe, K Marks, S Gross, E Murphy, B DeLaBarre, ... Chemistry & biology 19 (9), 1187-1198, 2012 | 192 | 2012 |
| c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo Z Shao, K Bhattacharya, E Hsich, L Park, B Walters, U Germann, ... Circulation research 98 (1), 111-118, 2006 | 181 | 2006 |
| Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases. FG Salituro, UA Germann, KP Wilson, GW Bemis, T Fox, MS Su Current Medicinal Chemistry 6 (9), 807-823, 1999 | 156 | 1999 |
| Pyrrolopyridines useful as inhibitors of protein kinase M Ledeboer, M Wannamaker, L Farmer, T Wang, A Pierce, ... US Patent 8,921,376, 2014 | 154 | 2014 |
| Activity of 5, 7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site. BM Baron, BL Harrison, FP Miller, IA McDonald, FG Salituro, CJ Schmidt, ... Molecular Pharmacology 38 (4), 554-561, 1990 | 141 | 1990 |
| Substituted pyrrolo [2, 3-d] pyrimidines as inhibitors of protein kinases M Ledeboer, A Pierce, G Bemis, L Farmer, T Wang, D Messersmith, ... US Patent 8,633,205, 2014 | 122 | 2014 |
| Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition DH Rich, MS Bernatowicz, NS Agarwal, M Kawai, FG Salituro, ... Biochemistry 24 (13), 3165-3173, 1985 | 122 | 1985 |
| AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency C Kung, J Hixon, PA Kosinski, G Cianchetta, G Histen, Y Chen, C Hill, ... Blood, The Journal of the American Society of Hematology 130 (11), 1347-1356, 2017 | 105 | 2017 |
| Deazapurines useful as inhibitors of Janus kinases M Ledeboer, D Messersmith, F Maltais, H Gao, T Wang, J Cao, J Duffy, ... US Patent 8,741,912, 2014 | 97 | 2014 |
| Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases M Ledeboer, F Salituro, YC Moon US Patent App. 10/005,133, 2002 | 97 | 2002 |
| Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator AL Althaus, MA Ackley, GM Belfort, SM Gee, J Dai, DP Nguyen, ... Neuropharmacology 181, 108333, 2020 | 94 | 2020 |
| Discovery of VX-509 (decernotinib): a potent and selective Janus kinase 3 inhibitor for the treatment of autoimmune diseases LJ Farmer, MW Ledeboer, T Hoock, MJ Arnost, RS Bethiel, YL Bennani, ... Journal of medicinal chemistry 58 (18), 7195-7216, 2015 | 94 | 2015 |
| Diaminotriazoles useful as inhibitors of protein kinases AC Pierce, M Amost, RJ Davies, CJ Forster, V Galullo, R Grey Jr, ... US Patent 7,279,469, 2007 | 93 | 2007 |
